|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910813600703321 |
|
|
Autore |
Kingah Stephen |
|
|
Titolo |
Access to medicines and vaccines in the South : coherence of rules and policies applied by the European Union Commission / / Stephen Kingah |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Brussels, Belgium : , : VUBPress, , 2011 |
|
©2011 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (282 p.) |
|
|
|
|
|
|
Collana |
|
Institute for European Studies - publication series ; ; Number 20 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drug accessibility - Developing countries |
Pharmaceutical policy - European Union countries |
Medical care, Cost of - Developing countries |
Public health - Developing countries |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
Table of contents -- Acknowledgement -- Preface -- Chapter 1: Introduction: using coherence to understand the problem -- Chapter 2: The international law and political economy of access to affordable medicines in the South -- Chapter 3: The coherence of EU primary and secondary rules and the goal of access to medicines in the South: substantive coherence -- Chapter 4: Institutional coherence for access to medicines and vaccines in the South: the case of the European Commission, the Parliament and the Council -- Chapter 5: Adjudicative coherence for access to affordable medicines and vaccines in the South: approaches of the court of justice (CJ) and the European Committee on social rightsChapter Six " Conclusions: A checklist for EU coherence for access and the way forward -- Epilogue -- Bibliography -- Official EC documents -- List of cases of the European court of justice -- List of WTO cases -- Other cases -- Interviews -- List of abbreviations. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
How can developing countries maximize some of the beneficial rules and policies provided to them by the EU and international organizations to reduce public health plight in terms of inadequate access to medicines and vaccines? By navigating some of the complex European |
|
|
|
|